Healio Rheumatology


The following articles appeared in the print edition of HEALIO RHEUMATOLOGY.

Table of Contents

CreakyJoints Releases Patient-centered Gout Guidelines

Experts say Trump’s Plan to Lower Drug Prices Misses Mark, Unlikely to Work

Ethnicity, Hypertension Predict Gout Risk, Unexplained by Urate Level

Gout Not Linked to Increased Risk for Bone Fracture

ACP: Trump’s Rescission Package Would Harm Public Health

Cover Story

Wellness for a Life Well-lived, Even With Rheumatic Disease

Drug Pipeline

Otezla Safe, Effective as Monotherapy for Patients With PsA

Pilot Study To Assess Bone Effects of Cosentyx in Ankylosing Spondylitis

FDA Approves Actemra Subcutaneous Injection for Polyarticular JIA

FDA Declines Proposed Rituxan Biosimilar From Sandoz


Wellness and Rheumatology: Is it Important and Whose Job is it to Achieve?

Leonard H. Calabrese, DO

Education Lab

Ace the Case: 60-Year-Old Woman With Recurrent Infections and Bronchitis


EULAR Addresses Arterial Involvement in Updated Behçet’s Syndrome Recommendations

EULAR Releases Pain Management Recommendations for OA, Inflammatory Arthritis

In the Journals

Long-term TNF Inhibitor Retention High in Spondyloarthritis

Lymphoma Rates in Xeljanz Clinical Trials for RA Stable

Patient’s Relationship With Rheumatologist Affects Perception of Medication

Widespread Pain More Prevalent in Women With Spondyloarthritis

Blacks With Lupus Have Higher Comorbidity Burden Than Whites

Actemra for Systemic JIA Yields 75% Remission Rate After 1 Year

Lost Productivity Costs High for SLE, Sjögren’s, Systemic Sclerosis

Meet the Board

Meet the Board: Stanley Cohen, MD, Strikes Balance of Academic Focus With Private Practice

Meeting News

SAMBA: Integrated Model Improves Quality of Care for Hip/Knee OA

Concerns Remain Over OA-related Morbidity, Mortality After OARSI White Paper

‘Replacing Prednisone’ Remains Top Priority for Emerging Vasculitis Therapies

CANTOS: ‘Inflammation is the New Cholesterol’ to Reduce CV Risk

Patients With Multiple Autoimmune Diseases Have Unique Concerns, Physician Needs

BE ACTIVE: IL-17F, IL-17A Blockade May ‘Push the Envelope’ for PsA Treatment

NSAIDS, Calcium Supplements May Exacerbate SLE Comorbidities

Duration of Knee, Hip OA May Increase Cardiovascular Mortality

MIV-711 Fails to Meet Primary Pain Endpoint in Knee OA

Step Rate Linked With Knee Cartilage Damage in Women


Where Change is the NORM: Guiding Rheumatology Practice Managers Through a Field in Flux

Trend Watch

Trump Unveils Long-Promised Plan to Lower Drug Prices

ACR Develops Rheumatology Training Tool for NPs, PAs

‘Right to Try’ Impact on Patients Uncertain

ACR Warns CMS Against Extending Duration of Short-term Insurance Plans